Cooper Investors PTY Ltd. lowered its holdings in CME Group Inc. (NASDAQ:CME – Free Report) by 4.9% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 127,313 shares of the financial services provider’s stock after selling 6,596 shares during the quarter. CME Group makes up 5.5% of Cooper Investors PTY Ltd.’s portfolio, making the stock its 3rd biggest position. Cooper Investors PTY Ltd.’s holdings in CME Group were worth $33,775,000 as of its most recent SEC filing.
Several other large investors have also modified their holdings of the business. Legacy Advisors LLC raised its holdings in shares of CME Group by 14.8% in the 1st quarter. Legacy Advisors LLC now owns 8,674 shares of the financial services provider’s stock valued at $2,301,000 after purchasing an additional 1,117 shares in the last quarter. Asset Management One Co. Ltd. raised its holdings in shares of CME Group by 2.5% in the 1st quarter. Asset Management One Co. Ltd. now owns 213,013 shares of the financial services provider’s stock valued at $56,510,000 after purchasing an additional 5,284 shares in the last quarter. GHP Investment Advisors Inc. raised its holdings in shares of CME Group by 13.2% in the 1st quarter. GHP Investment Advisors Inc. now owns 23,114 shares of the financial services provider’s stock valued at $6,132,000 after purchasing an additional 2,694 shares in the last quarter. Oppenheimer & Co. Inc. raised its holdings in shares of CME Group by 0.7% in the 1st quarter. Oppenheimer & Co. Inc. now owns 36,291 shares of the financial services provider’s stock valued at $9,628,000 after purchasing an additional 246 shares in the last quarter. Finally, Sawgrass Asset Management LLC raised its holdings in shares of CME Group by 2,620.9% in the 1st quarter. Sawgrass Asset Management LLC now owns 24,733 shares of the financial services provider’s stock valued at $6,561,000 after purchasing an additional 23,824 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.
Analysts Set New Price Targets
A number of research analysts have recently issued reports on CME shares. Erste Group Bank downgraded shares of CME Group from a “strong-buy” rating to a “hold” rating in a research report on Saturday, May 24th. Piper Sandler lifted their price objective on shares of CME Group from $275.00 to $283.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 8th. Barclays lifted their price objective on shares of CME Group from $279.00 to $283.00 and gave the stock an “equal weight” rating in a research report on Wednesday, April 23rd. Raymond James Financial raised shares of CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 price objective on the stock in a research report on Monday, March 10th. Finally, JPMorgan Chase & Co. cut their price objective on shares of CME Group from $223.00 to $211.00 and set an “underweight” rating on the stock in a research report on Thursday, April 24th. Three investment analysts have rated the stock with a sell rating, eight have issued a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, CME Group currently has an average rating of “Hold” and an average price target of $258.20.
CME Group Stock Down 0.5%
NASDAQ:CME opened at $272.66 on Tuesday. The company has a market cap of $98.26 billion, a PE ratio of 27.43, a P/E/G ratio of 3.72 and a beta of 0.45. CME Group Inc. has a twelve month low of $192.11 and a twelve month high of $290.79. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The company’s 50 day moving average is $274.35 and its two-hundred day moving average is $255.81.
CME Group (NASDAQ:CME – Get Free Report) last released its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.61 by $0.19. The company had revenue of $1.64 billion for the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a net margin of 57.71% and a return on equity of 14.03%. CME Group’s revenue was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.50 EPS. Analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.
CME Group Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.83%. The ex-dividend date is Monday, June 9th. CME Group’s dividend payout ratio is presently 50.30%.
Insiders Place Their Bets
In other news, Director Charles P. Carey sold 500 shares of the company’s stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $265.35, for a total value of $132,675.00. Following the sale, the director now directly owns 4,900 shares of the company’s stock, valued at $1,300,215. This represents a 9.26% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Dennis Suskind sold 1,000 shares of the company’s stock in a transaction on Tuesday, April 29th. The shares were sold at an average price of $271.28, for a total transaction of $271,280.00. Following the completion of the sale, the director now directly owns 2,915 shares in the company, valued at $790,781.20. This trade represents a 25.54% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 13,400 shares of company stock valued at $3,680,610. Insiders own 0.30% of the company’s stock.
CME Group Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Stories
- Five stocks we like better than CME Group
- Why Are These Companies Considered Blue Chips?
- Microsoft Stock Holds Steady as AI Drives Workforce Shift
- The 3 Best Retail Stocks to Shop for in August
- D-Wave Goes International With South Korea Partnership
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Payment Giants Slide on Stablecoin Buzz—Is Now the Time to Buy?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.